IDEAYA Biosciences, Inc. IDYA
- IDE849 — Small Cell Lung Cancer Phase 1
- IDE849 — Neuroendocrine Carcinoma Phase 1
DLL3 (4 companies · 6 programs)
Companies with an active program directed at DLL3.
Legend Biotech Corp LEGN
- LB2102 — Small Cell Lung Cancer Phase 1
- LB2102 — Large Cell Neuroendocrine Carcinoma Phase 1
Allogene Therapeutics, Inc. ALLO
- ALLO-213 — Small Cell Lung Cancer
Zymeworks Inc. ZYME
- ZW209 — Small Cell Lung Cancer Preclinical